Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02459769 · ClinicalTrials.gov registry record · NA

Exercise Intervention for LGBT Cancer Survivors

A NA study of Neoplasms, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT02459769 is a NA study of Neoplasms that has completed, run by University of Rochester. The registered enrollment target is 140 participants, below the 1,620-participant average among 158 other Neoplasms trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02459769, a NA study of Neoplasms, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test preliminary efficacy, as well as acceptability and feasibility, of a dyadic exercise intervention, the current study will randomize LGBT cancer survivors and their non-professional caregivers as dyads to either an individual or a dyadic Exercise for Cancer Patients (EXCAP) intervention. The primary outcome assessed will be psychological distress. Analyses will involve pre-post comparisons of outcomes across the study arms, testing the hypothesis that a 6 week, daily, dyadic exercise intervention will result in greater improvements in psychological distress than an individual intervention.

Conditions Studied

Neoplasms

Interventions

  • BEHAVIORAL Exercise for Cancer Patients

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2015-08-15
Est. Completion 2021-02-22
Phase NA

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02459769

The ClinicalTrials.gov registry entry for NCT02459769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,620-participant average among 158 other Neoplasms trials with a reported enrollment target (91% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Exercise for Cancer Patients is the first listed.

NCT02459769 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02459769 about?

NCT02459769 is a clinical study titled "Exercise Intervention for LGBT Cancer Survivors". The purpose of this study is to test preliminary efficacy, as well as acceptability and feasibility, of a dyadic exercise intervention, the current study will randomize LGBT cancer survivors and their non-professional caregivers as dyads to either an individual or a dyadic Exercise for Cancer Patien...

What is the current status of trial NCT02459769?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2015-08-15. Estimated completion is 2021-02-22.

What conditions does trial NCT02459769 study?

This clinical trial studies the following conditions: Neoplasms.

What interventions are being tested in trial NCT02459769?

The interventions under investigation include: Exercise for Cancer Patients (BEHAVIORAL).

Who is sponsoring clinical trial NCT02459769?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02459769 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neoplasms

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.